AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)
The AAP leader's remarks came a day after British pharma giant AstraZeneca admitted in a UK court that its anti-COVID vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases."?
The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases".?
The vaccine producer stated in court documents that the inoculation could occasionally induce Thrombosis with Thrombocytopenia Syndrome (TTS), a disorder resulting in blood clots and a reduced platelet count, as reported in The Telegraph.
Copyright?2025 Living Media India Limited. For reprint rights: Syndications Today